Common clinicopathologic parameters included with CRP were: stage (TNM, Dukes, others) 23% (59/256); metastasis (lymph node, liver, others) 17%; performance status (ECOG, KPS, others) 16%; tumor characteristics (histology, site, diameter, size) 16%; WBC 13%. The gene discussed is CRP; the disease is neoplasm.